Results 1 to 10 of about 10,125,713 (289)

Statins in Non-alcoholic Steatohepatitis [PDF]

open access: yesFrontiers in Cardiovascular Medicine, 2021
Non-alcoholic fatty liver disease (NAFLD) is the primary cause of chronic liver disease. The range is extensive, including hepatocellular carcinoma, cirrhosis, fibrosis, fatty liver, and non-alcoholic steatohepatitis (NASH).
Jose D. Torres-Peña   +5 more
doaj   +5 more sources

Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol

open access: yesNature Communications, 2023
The interplay between western diet and gut microbiota drives the development of non-alcoholic fatty liver disease and its progression to non-alcoholic steatohepatitis.
Shi-You Chen   +2 more
exaly   +2 more sources

Сomparative Study of Progepar Efficacy in Patients with Non-Alcoholic Steatohepatitis

open access: yesGastroenterologìa, 2015
Non-alcoholic fatty liver disease is one of the most common pathologies of the liver in developed countries. On the average, its prevalence reaches 20 %.
V.G. Perederii, G.K. Syzenko
doaj   +2 more sources

Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation [PDF]

open access: yesArquivos de Gastroenterologia, 2001
Background — Non-alcoholic steatohepatitis was coined in 1980 to describe pathological and clinical features of non-alcoholic disease associated with pathological features, commonly seen in alcoholic-liver disease itself.
Raquel F. Liermann GARCIA   +5 more
doaj   +1 more source

Metabolomic Predictors of Non-alcoholic Steatohepatitis and Advanced Fibrosis in Children

open access: yesFrontiers in Microbiology, 2021
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in western countries both in children and adults. Metabolic dysregulation associated with gut microbial dysbiosis may influence disease progression from hepatic ...
Kattayoun Kordy   +12 more
doaj   +1 more source

Treatments for NAFLD [PDF]

open access: yesFarmacja Polska, 2021
Non-alcoholic fatty liver disease (NAFLD) is categorised into simple steatosis, termed nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH).
Katarzyna Juszczyńska
doaj   +1 more source

Structure of anaemic conditions comorbid to alcoholic and non-alcoholic steatohepatitis

open access: yesJournal of Education, Health and Sport, 2021
The retrospective analysis of 378 medical records of inpatients with steatohepatitis (SH) depending on its etiology was performed to identify and study the type of anaemic conditions (AC).
Oksana Khukhlina   +2 more
doaj   +1 more source

Burden of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus

open access: yesDiabetology & Metabolic Syndrome, 2021
This claims-based retrospective cohort study examined the prevalence and incremental impact of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus in the United States.
Lauren Parlett   +6 more
doaj   +1 more source

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS [PDF]

open access: yesRomanian Medical Journal, 2018
Non-alcoholic fatty liver comprises several clinical entities, starting from hepatic steatosis and reaching steatohepatitis, fibrosis and liver cirrhosis; it is currently considered a major public health issue.
Anca Smaranda Farmazon   +6 more
doaj   +1 more source

Correlation of serum aspartate aminotransferase level to platelet count ratio index with non-alcoholic fatty liver disease activity score

open access: yesBangabandhu Sheikh Mujib Medical University Journal, 2019
In case of non-alcoholic fatty liver disease, the ratio of serum aspartate  aminotransferase (AST) level to platelet count index has been proposed as a non-invasive and readily available tool for the assessment of non-alcoholic steatohepatitis. The study
Dulal Chandra Das   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy